After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, BSX falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Boston Scientific Corp is $148.93B. A total of 8.62 million shares were traded on the day, compared to an average of 6.64M shares.
In the most recent transaction, VANCE BROWN bought 4,826 shares of BSX for 100.85 per share on Mar 21 ’25. In a previous transaction on Mar 03 ’25, Woodworth Emily sold 7,149 shares at 104.97 per share. BSX shares that SVP, Global Controller and CAO owns now total 914.
Among the insiders who sold shares, Woodworth Emily disposed of 482 shares on Mar 04 ’25 at a per-share price of $104.63. This resulted in the SVP, Global Controller and CAO holding 432 shares of BSX after the transaction. In another insider transaction, Woodworth Emily sold 9,887 shares at $101.13 per share on Feb 28 ’25. Company shares held by the SVP, Global Controller and CAO now total 1,632.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, BSX has a high of $107.17 and a low of $66.80.
As of this writing, BSX has an earnings estimate of $0.67 per share for the current quarter. EPS was calculated based on a consensus of 25.0 estimates, with a high estimate of $0.68 per share and a lower estimate of $0.66.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $14.76, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.82.
